While Ventas' (VTR) office segment has upside potential due to the high need for research related to life-saving vaccines, the challenging senior housing operating environment remains a hurdle.

Ventas, Inc. has earned the 2020 Nareit Health Care "Leader in the Light" award for a fourth consecutive year.

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 817 world-class investment firms that we track and now have access to the collective wisdom contained in […]

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on January 20, 2021 to stockholders of record as of the close of business on January 4, 2021.

Healthcare real estate investment trusts (REITs) have struggled this year. One property type that's becoming increasingly valuable is life science buildings. With funding for research on vaccines, therapeutics, and diagnostics likely to increase in the coming years, these properties will become more crucial.

Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.